A New Lab-Made COVID-19 Virus Puts Gain-of-Function Research Under the Microscope
On October 14, a team of scientists at Boston University released a pre-print study reporting that they had created a version of SARS-CoV-2 combining two features of different, existing strains that boosted its virulence and transmissibility. Scientists and the public raised questions about the work, which refocused attention on such experiments, and prompted the U.S. government to investigate whether the research followed protocols for these kinds of studies. The concerns surround what is known as gain-of-function studies, in which viruses, bacteria, or other pathogens are created in the lab—either intentionally or ...
Source: TIME: Science - October 27, 2022 Category: Science Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

U.S. weighs crackdown on experiments that could make viruses more dangerous
.news-article__hero--featured .parallax__element{ object-position: 50% 40%; -o-object-position: 50% 40%; } .scroll-wrapper { overflow-x: auto; } .scroll-wrapper .news-article__figure__image{ width: 2680px; max-width: none; padding-bottom: .75rem; } .scroll-fade-before, .scroll-fade-after { position: absolute; width: 1.5rem; transition-duration: .1s; opacity: 1; } .scroll-fade-before { left: 1rem; /*margin-left: -1px;*/ background: linear-gradient(90deg, #fff, #fff 35%, hsla(0, 0%, 100%, 0)); } .scroll-fade-after { right: 1rem; /*margin-right: -1px;*/ background: linear-gradient(270deg, #fff, #fff 3...
Source: ScienceNOW - October 19, 2022 Category: Science Source Type: news

Roche announces U.S. FDA approval of Xofluza to treat influenza in children aged five years and older
Xofluza is the first and only single-dose oral medicine for the treatment of influenza to be approved in the US for children as young as five years of ageThe FDA also approved Xofluza to prevent influenza in children aged five years and older following contact with an infected personBasel, 12 August 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for Xofluza ® (baloxavir marboxil) for the treatment of acute uncomplicated influenza in otherwise healthy children aged five to less than 12 years o...
Source: Roche Investor Update - August 12, 2022 Category: Pharmaceuticals Source Type: news

Roche announces U.S. FDA approval of Xofluza to treat influenza in children aged five years and older
Xofluza is the first and only single-dose oral medicine for the treatment of influenza to be approved in the US for children as young as five years of ageThe FDA also approved Xofluza to prevent influenza in children aged five years and older following contact with an infected personBasel, 12 August 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for Xofluza ® (baloxavir marboxil) for the treatment of acute uncomplicated influenza in otherwise healthy children aged five to less than 12 years o...
Source: Roche Media News - August 12, 2022 Category: Pharmaceuticals Source Type: news

GSK signs agreement to support pandemic preparedness in Europe
GSK plc (LSE/NYSE: GSK) announced it had signed a framework contract with the European Commission's (EC) Health Emergency Preparedness and Response Authority (HERA) for the reservation of future production and supply of 85 million doses of its pandemic influenza vaccine Adjupanrix [pandemic influenza vaccine (split virion, inactivated, adjuvanted)]. (Source: World Pharma News)
Source: World Pharma News - August 1, 2022 Category: Pharmaceuticals Tags: Featured GlaxoSmithKline Business and Industry Source Type: news

Wrestling with bird flu, Europe considers once-taboo vaccines
Science,<a href="https://www.science.org/toc/science/376/6594">Volume 376, Issue 6594</a>, Page 682-683, May 2022. (Source: ScienceNOW)
Source: ScienceNOW - May 12, 2022 Category: Science Authors: Erik Stokstad Source Type: news

H5N1 Vaccine Readied for a Possible Influenza Pandemic H5N1 Vaccine Readied for a Possible Influenza Pandemic
Adjuvanted H5N1 influenza vaccine has been shown to be highly immunogenic in younger and older adults. It is being developed in light of a possible H5N1 influenza pandemic that could cause global harm.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 8, 2022 Category: Allergy & Immunology Tags: Infectious Diseases News Source Type: news

Bless you! Meet the flu hunters trying to stop the next pandemic in its tracks
Remember flu? Despite lockdowns holding it at bay, a small group of scientists is searching the globe for deadly new strains – and to work out what to put in next winter’s vaccinesLast month, a small group of international scientists met to decide an issue critical to the health of millions of people all over the planet. For once, it wasn ’t about coronavirus, although these experts know a lot about that, too. The task in hand was to save us from a bug we’ve been fighting since before the days of Hippocrates, the first doctor to describe it in 400BC. It’s an adversary potentially as much of a threat as Covid. The...
Source: Guardian Unlimited Science - March 19, 2022 Category: Science Authors: Sarah Boseley. Portraits: David Levene Tags: Flu Vaccines and immunisation Bird flu Health Society Flu pandemic & wellbeing World Health Organization Coronavirus Infectious diseases Life and style Medical research Science World news Microbiology Source Type: news

Influenza Vaccinations During the COVID-19 Pandemic Influenza Vaccinations During the COVID-19 Pandemic
This report assessed the potential impact of the COVID-19 pandemic on influenza vaccination coverage. How did vaccination during Sept-Dec 2020 compare with the corresponding period in prior years?Morbidity & Mortality Weekly Report (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 31, 2022 Category: Consumer Health News Tags: Public Health & Prevention Journal Article Source Type: news

Fully Ready to Kill, Shockingly Unprepared to Save Lives
Credit: Albert Gonzalez Farran / UNAMIDBy Baher KamalMADRID, Jan 14 2022 (IPS) While absolutely ready to kill, with the biggest military powers spending in 2020 nearly two trillion US dollars on weapons, the world is shockingly unprepared to save the lives of millions of unarmed, innocent civilian victims of wars… and other man-made catastrophes. The military spending data come from the Stockholm International Peace Research Institute (SIPRI), which also reports that global nuclear arsenals grow as states continue to modernise, thus sharply increasing the dangers of an unimaginable number of victims of the most devastati...
Source: IPS Inter Press Service - Health - January 14, 2022 Category: International Medicine & Public Health Authors: Baher Kamal Tags: Development & Aid Economy & Trade Global Global Governance Headlines Health Peace Poverty & SDGs TerraViva United Nations Source Type: news

Africa Should Bargain Hard for COVID Vaccine Equity: Lessons from Indonesia during Avian Flu
The Republic of Congo received just over 300,000 doses of the COVID vaccines through the COVAX Facility in August 2021. The international COVAX initiative aimed at guaranteeing global access to the vaccines, recently announced that it was being forced to slash planned deliveries to Africa, by around 150 million doses this year. The scheme is now expected to deliver 470 million doses through the end of December. These will be enough to protect just 17 per cent of the continent, far below the 40 per cent target, according to the World Health Organization (WHO). Credit: UNICEF/Aimable TwiringiyimaBy Victoria Fan and Steve Kuo...
Source: IPS Inter Press Service - Health - December 6, 2021 Category: International Medicine & Public Health Authors: Victoria Fan and Steve Kuo Tags: Africa COVID-19 COVID-19 VACCINES Development & Aid Economy & Trade Featured Financial Crisis Headlines Health TerraViva United Nations Trade & Investment IPS UN Bureau Source Type: news

Holly Springs plant secures $34.95M contract for flu vaccine development
The federal government has awarded the drug manufacturer a $34.95 million contract to develop two pandemic influenza vaccines. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 5, 2021 Category: Pharmaceuticals Authors: Zac Ezzone Source Type: news

Could gene editing chickens prevent future pandemics?
Rearing virus-resistant birds could benefit humans too, say scientists, and Covid may have made us more open to the controversial technologyDiseases such as avian flu trigger the culling of millions of birds each year. But that need not be the case for much longer.Vaccines are one preventive strategy employed in some countries, but they do not stop birds from being infected, getting mild versions of the disease and transmitting it to healthy chickens. In fact, this imperfect shield can make things worse, incentivising the virus to mutate to evade the vaccine.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - September 18, 2021 Category: Science Authors: Natalie Grover Tags: Gene editing Bird flu Environment Health Society Coronavirus Infectious diseases Medical research Science Chicken Food World news Animals Source Type: news

Coronavirus live news: India deaths pass 200,000; crisis needs global response – Fauci
India hits another global record;US expert says richer countries must do more to help fight crisis in IndiaWorld has failed India, says US expert Dr FauciFears of Covid ‘tsunami’ as India variant drives outbreakSingle vaccine dose found to nearly halve transmissionSpain to welcome overseas travellers with Covid certificates from JuneSee all our coronavirus coverage8.25amBSTThere ’s been some reaction in the UK media tothe Public Health England study that shows vaccines cutting transmission rates in England as well as preventing more serious infection symptoms.Dr Mike Tildesley, from the University of Warwick and a me...
Source: Guardian Unlimited Science - April 28, 2021 Category: Science Authors: Martin Belam (now) and Martin Farrer (earlier) Tags: Coronavirus India Science Infectious diseases US news Source Type: news